Case Studies of Patients Who Had Experienced Near Death Experience

• Sponsor: Seoul National University Hospital (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05544799
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Anticipated Duration (Months): 107.9
• Patients Per Site Per Month: 1.9

Study Details

Study Description

Brief Summary

An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward.

Condition or Disease	Intervention/Treatment	Phase
Near Death Experience	Other: No intervention

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 200 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Case Studies of Patients Who Had Experienced Near Death Experience
• Actual Study Start Date: Jan 3, 2021
• Anticipated Primary Completion Date: Dec 31, 2024
• Anticipated Study Completion Date: Dec 31, 2029

Outcome Measures

Primary Outcome Measures

1. Incidence of near death experience (NDE) [5 years]

   Incidence of case with NDE scale ≥7 point

Eligibility Criteria

Criteria

• Ages Eligible for Study: 19 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Adult patients (≥19yrs) who are in admission in the Hematology ward of Seoul National University Hospital, and one of the following conditions.

1. recovered after cardiopulomary resuscitation

2. recovered after mechanical ventilator

3. recovered after ICU care

4. recovered after emergent operation

5. recovered after Shock, coma, altered mentality

6. Other medical conditions approaching death

Exclusion Criteria:

1. Those who do not agree to participate this study

2. Those who can not be interviewed due to insufficient recovery from critical medical problems

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Seoul National University Hospital	Seoul		Korea, Republic of	03080

Sponsors and Collaborators

• Seoul National University Hospital

Investigators

• Principal Investigator: Dong-Yeop Shin, MD, PhD, Department of Internal Medicine, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Dong-Yeop Shin, Professor, Seoul National University Hospital
• ClinicalTrials.gov Identifier: NCT05544799
• Other Study ID Numbers: K-NDE
• First Posted: Sep 16, 2022
• Last Update Posted: Sep 16, 2022
• Last Verified: Sep 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Death

Study Results

No Results Posted as of Sep 16, 2022